@article{a07c9b3032b84751992b0c2f3811cf4d,
title = "Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.",
abstract = "Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.",
keywords = "lung cancer, lung cancer",
author = "Lucio Trodella and D'Angelillo, {Rolando Maria} and Sara Ramella and Numa Cellini and Marzia Ciresa and Alfredo Cesario and Pierluigi Granone and L. Trodella and D'Angelillo, {R. M.} and S. Ramella and F. Cellini and M. Ciresa",
year = "2006",
language = "English",
pages = "52--54",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Attuale:OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP Kluwer Academic Publishers:Journals Department, PO Box 322, 3300 AH Dordrecht Netherlands:011 31 78 6576050, EMAIL: frontoffice@wkap.nl, kluweronline@wkap.nl, INTERNET: http://www.kluwerlaw.com, Fax: 011 31 78 6576254",
}